NCT02623309View on ClinicalTrials.gov

Studyof Allogeneic Hematopoietic Stem Cell Transplantation From One Haplotype Mismatch Related Donor or From an Unrelated Donor in Elderly Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

February 23, 2016

Primary Completion Date

February 2, 2021

Study Completion Date

March 12, 2021

Conditions
Hematologic Neoplasms
Interventions
BIOLOGICAL

Allogeneic (Allo) hematopoietic stem cell transplantation

Trial Locations (14)

13009

Institut Paoli Calmettes, Marseille

Unknown

CHU Amiens, Amiens

CHU Besançon, Besançon

CHU Estaing/Clermont-ferrand, Clermont-Ferrand

CHU Albert Michallon, Grenoble

CHU Limoges, Limoges

CHRU Montpellier, Montpellier

CHU Nantes, Nantes

Hôpital Necker, Paris

Hôpital Saint Antoine, Paris

Hôpital Saint Louis, Paris

Hôpital Haut Leveque, Pessac

Institut de Cancérologie Lucien Neuwirth, Saint-Priest-en-Jarez

IUCT, Toulouse

All Listed Sponsors
lead

Institut Paoli-Calmettes

OTHER

NCT02623309 - Studyof Allogeneic Hematopoietic Stem Cell Transplantation From One Haplotype Mismatch Related Donor or From an Unrelated Donor in Elderly Patients | Biotech Hunter | Biotech Hunter